Barclays’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Barclays's TAK Position: Q3 2026 in Review
Barclays increased its Takeda Pharmaceutical (TAK) stake by 1,255% in Q3 2026, buying an estimated $1.06M and bringing the position to 64,911 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2927.
Barclays first reported a position in TAK in Q4 2018 and has held it in 32 quarters since. The position peaked at $27.9M in Q1 2023. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Barclays held 64,911 shares of Takeda Pharmaceutical worth $1.18M as of Q3 2026.
- Barclays bought 60,119 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.06M.
- Takeda Pharmaceutical made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2927 holding.
- Barclays first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 32 quarters since.
- Barclays's Takeda Pharmaceutical position peaked at $27.9M in Q1 2023.
- 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.